Abstract:A method to assemble stimuli-responsive nucleic acid-based hydrogel-stabilized microcapsule-in-microcapsule systems is introduced. An inner aqueous compartment stabilized by a stimuli-responsive hydrogel-layer (∼150 nm) provides the inner microcapsule (diameter ∼2.5 μm). The inner microcapsule is separated from an outer aqueous compartment stabilized by an outer stimuli-responsive hydrogel layer (thickness of ∼150 nm) that yields the microcapsule-in-microcapsule system. Different loads, e.g., tetramethyl rhodamine-dextran (TMR-D) and CdSe/ZnS quantum dots (QDs), are loaded in the inner and outer aqueous compartments. The hydrogel layers exist in a higher stiffness state that prevents inter-reservoir or leakage of the loads from the respective aqueous compartments. Subjecting the inner hydrogel layer to Zn<sup>2+</sup>-ions and/or the outer hydrogel layer to acidic pH or crown ether leads to the triggered separation of the bridging units associated with the respective hydrogel layers. This results in the hydrogel layers of lower stiffness allowing either the mixing of the loads occupying the two aqueous compartments, the guided release of the load from the outer aqueous compartment, or the release of the loads from the two aqueous compartments. In addition, a pH-responsive microcapsule-in-microcapsule system is loaded with glucose oxidase (GOx) in the inner aqueous compartment and insulin in the outer aqueous compartment. Glucose permeates across the two hydrogel layers resulting in the GOx catalyzed aerobic oxidation of glucose to gluconic acid. The acidification of the microcapsule-in-microcapsule system leads to the triggered unlocking of the outer, pH-responsive hydrogel layer and to the release of insulin. The pH-stimulated release of insulin is controlled by the concentration of glucose. While at normal glucose levels, the release of insulin is practically prohibited, the dose-controlled release of insulin in the entire diabetic range is demonstrated. Also, switchable ON/OFF release of insulin is achieved highlighting an autonomous glucose-responsive microdevice operating as an "artificial pancreas" for the release of insulin.

Glucose‐Triggered Gelation of Supramolecular Peptide Nanocoils with Glucose‐Binding Motifs (Adv. Mater. 16/2024)

Engineering Supramolecular Nanofiber Depots from a Glucagon-Like Peptide-1 Therapeutic

Injectable Nano-Network for Glucose-Mediated Insulin Delivery.

An Engineered Nanosugar Enables Rapid and Sustained Glucose‐Responsive Insulin Delivery in Diabetic Mice (Adv. Mater. 21/2023)

Facile Preparation of Cancer-Specific Polyelectrolyte Nanogels from Natural and Synthetic Sugar Polymers

Insulin–Dendrimer Nanocomplex for Multi‐Day Glucose‐Responsive Therapy in Mice and Swine (Adv. Mater. 5/2024)

Glucose and H2O2 dual-sensitive nanogels for enhanced glucose-responsive insulin delivery

Glucose‐Responsive Fibrin Hydrogel‐Based Multimodal Nucleic Acid Delivery System

Glucose-Responsive Peptide Coacervates with High Encapsulation Efficiency for Controlled Release of Insulin.

Glucose-responsive Microgels Integrated with Enzyme Nanocapsules for Closed-Loop Insulin Delivery.

Glucose‐Induced Disintegrated Hydrogel for the Glucose‐Responsive Delivery of Insulin

Dextran-crosslinked Glucose Responsive Nanogels with a Self-Regulated Insulin Release at Physiological Conditions

Triggered Release of Loads from Microcapsule-in-Microcapsule Hydrogel Microcarriers: En-Route to an “Artificial Pancreas”

Engineering Synthetic Insulin-Secreting Cells Using Hyaluronic Acid Microgels Integrated with Glucose-Responsive Nanoparticles

Glucose Oxidase‐Immobilized Dually‐Crosslinked Nanogels for Rapid‐Responsive Insulin Delivery

Glucose-responsive hydrogels based on dynamic covalent chemistry and inclusion complexation.

An Injectable PEG-BSA-Coumarin-GOx Hydrogel for Fluorescence Turn-on Glucose Detection

On demand regulation of blood glucose level by biocompatible oxidized starch-Con A nanogels for glucose-responsive release of exenatide

Bio-Inspired Synthetic Nanovesicles for Glucose-Responsive Release of Insulin

Glucose-Responsive Supramolecular Vesicles Based on Water-Soluble Pillar[5]arene and Pyridylboronic Acid Derivatives for Controlled Insulin Delivery

Glucose-regulated Insulin Release from Acid-Disintegrable Microgels Covalently Immobilized with Glucose Oxidase and Catalase.